TrialBlood cancer journal2018

Daratumumab, lenalidomide, and dexamethasone in East Asian patients with relapsed or refractory multiple myeloma: subgroup analyses of the phase 3 POLLUX study.

Kenshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.